Source:http://linkedlifedata.com/resource/pubmed/id/15785046
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2005-3-23
|
pubmed:abstractText |
Chronic plaque-type psoriasis is a major dermatosis, but a significant question is still unanswered: What defines severity in chronic plaque-type psoriasis? While objective assessments like the Psoriasis Area and Severity Index (PASI) have frequently been used in clinical trials, quality of life (QOL) questionnaires are currently becoming more and more popular.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1018-8665
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
210
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
194-9
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading | |
pubmed:year |
2005
|
pubmed:articleTitle |
The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis.
|
pubmed:affiliation |
Department of Dermatology, University Hospital Carl Gustav Carus, Technical University Dresden, DE-01307 Dresden, Germany. jm_schmitt@hotmail.com
|
pubmed:publicationType |
Journal Article,
Review
|